Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C

NCT01740089 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis
Hepatitis C

Interventions

DRUG: Algeron
DRUG: PegIntron
DRUG: Ribavirin

Sponsor

Biocad